Contingent value rights issued
Company: Core Scientific
The claim, verbatim
Core Scientific issued 2,192,027 contingent value rights entitling holders to certain cash payments upon the occurrence of specified events
Source (primary)
Core Scientific SC 13D/A filed 2024-01-25 (SEC EDGAR, sec_filing)
View cached copy (2026-08-31)Live source ↗
Quote: “acquired 2,192,027 contingent value rights that entitle the holders thereof to certain cash payments upon the occurrence of certain events”
How we checked this
Checked on September 18, 2026. The cited source supports part of this claim, but not all of it.
The 2,192,027 figure is the number of contingent value rights BlackRock acquired. The filing does not state the total number Core Scientific issued.
Confirmed in the source:
- Contingent value rights were distributed under Core Scientific's reorganization plan on January 23, 2024
- The contingent value rights entitle holders to certain cash payments upon the occurrence of certain events
- BlackRock acquired 2,192,027 of these contingent value rights
We could not confirm this from the cited source:
- That Core Scientific issued a total of 2,192,027 contingent value rights
That does not mean it is false — only that this source does not establish it, as of the date above. If we find a source that settles it, we will re-check and update this page.
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1839341/000119312524015411/d545166dsc13da.htm) in full (13,263 characters, retrieved August 31, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Core Scientific SC 13D/A filed 2024-01-25
Quote: “acquired 2,192,027 contingent value rights that entitle the holders thereof to certain cash payments upon the occurrence of certain events”